Direct presentation regulates the magnitude of the CD8+ T cell response to cell-associated antigen through prolonged T cell proliferation

Journal of Immunology

Volumn 185, Issue 5, 2010, Pages 2763-2772

  Tatum, Angela M ^a,b   Watson, Alan M ^a   Schell, Todd D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN P 15095; ONCOPROTEIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; VIRUS T ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL TRANSFORMATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNITY; IMMUNODOMINANCE HIERARCHY; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL; VACCINATION; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; CYTOTOXICITY TEST; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY; TIME; TRANSGENIC MOUSE; TRANSPLANTATION; VIRUS CELL TRANSFORMATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNIZATION SCHEDULE; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TIME FACTORS;

EID: 78049354212     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903920     Document Type: Article

References (59)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655.
2. Edwards, B. H., A. Bansal, S. Sabbaj, J. Bakari, M. J. Mulligan, and P. A. Goepfert. 2002. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76: 2298-2305.
3. Wang, L. X., S. Shu, and G. E. Plautz. 2005. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells. Cancer Res. 65: 9547-9554.
4. Tatum, A. M., L. M. Mylin, S. J. Bender, M. A. Fischer, B. A. Vigliotti, M. J. Tevethia, S. S. Tevethia, and T. D. Schell. 2008. CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J. Immunol. 181: 4406-4417.
5. Yorty, J. L., S. S. Tevethia, and T. D. Schell. 2008. Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors. Cancer Immunol. Immunother. 57: 883-895.
6. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
7. Blattman, J. N., R. Antia, D. J. Sourdive, X. Wang, S. M. Kaech, K. Murali-Krishna, J. D. Altman, and R. Ahmed. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195: 657-664.
8. Kotturi, M. F., I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette. 2008. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 181: 2124-2133.
9. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Kedl, and M. K. Jenkins. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
10. Obar, J. J., K. M. Khanna, and L. Lefrançois. 2008. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
11. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack. 2000. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192: 1105-1113.
12. Willis, R. A., J. W. Kappler, and P. C. Marrack. 2006. CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. USA 103: 12063-12068.
13. Grufman, P., E. Z. Wolpert, J. K. Sandberg, and K. Kärre. 1999. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens. Eur. J. Immunol. 29: 2197-2204.
14. Wolpert, E. Z., P. Grufman, J. K. Sandberg, A. Tegnesjö, and K. Kärre. 1998. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 161: 4499-4505.
15. Vijh, S., I. M. Pilip, and E. G. Pamer. 1999. Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection. Infect. Immun. 67: 1303-1309.
16. Bullock, T. N., D. W. Mullins, and V. H. Engelhard. 2003. Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J. Immunol. 170: 1822-1829.
17. La Gruta, N. L., K. Kedzierska, K. Pang, R. Webby, M. Davenport, W. Chen, S. J. Turner, and P. C. Doherty. 2006. A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 103: 994-999.
18. Porter, B. B., and J. T. Harty. 2006. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 74: 1528-1536.
19. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.
20. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class Irestricted tumor antigens. Science 264: 961-965.
21. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184: 923-930.
22. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
23. Chen, W., K. A. Masterman, S. Basta, S. M. Haeryfar, N. Dimopoulos, B. Knowles, J. R. Bennink, and J. W. Yewdell. 2004. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon. Eur. J. Immunol. 34: 194-199.
24. Ochsenbein, A. F., S. Sierro, B. Odermatt, M. Pericin, U. Karrer, J. Hermans, S. Hemmi, H. Hengartner, and R. M. Zinkernagel. 2001. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411: 1058-1064.
25. Wolkers, M. C., G. Stoetter, F. A. Vyth-Dreese, and T. N. Schumacher. 2001. Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses. J. Immunol. 167: 3577-3584.
26. Kündig, T. M., M. F. Bachmann, C. DiPaolo, J. J. Simard, M. Battegay, H. Lother, A. Gessner, K. Kühlcke, P. S. Ohashi, H. Hengartner, et al. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343-1347.
27. Otahal, P., S. C. Hutchinson, L. M. Mylin, M. J. Tevethia, S. S. Tevethia, and T. D. Schell. 2005. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope. J. Immunol. 175: 700-712.
28. Whalen, R. G., C. Leclerc, E. Dériaud, R. Schirmbeck, J. Reimann, and H. L. Davis. 1995. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. N. Y. Acad. Sci. 772: 64-76.
29. Shirota, H., L. Petrenko, C. Hong, and D. M. Klinman. 2007. Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity. J. Immunol. 179: 329-336.
30. Lauterbach, H., A. Gruber, C. Ried, C. Cheminay, and T. Brocker. 2006. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J. Immunol. 176: 4600-4607.
31. Thomas, S., G. A. Kolumam, and K. Murali-Krishna. 2007. Antigen presentation by nonhemopoietic cells amplifies clonal expansion of effector CD8 T cells in a pathogen-specific manner. J. Immunol. 178: 5802-5811.
32. Pavelic, V., M. S. Matter, S. Mumprecht, I. Breyer, and A. F. Ochsenbein. 2009. CTL induction by cross-priming is restricted to immunodominant epitopes. Eur. J. Immunol. 39: 704-716.
33. Mylin, L. M., T. D. Schell, D. Roberts, M. Epler, A. Boesteanu, E. J. Collins, J. A. Frelinger, S. Joyce, and S. S. Tevethia. 2000. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J. Virol. 74: 6922-6934.
34. Staveley-O'Carroll, K., T. D. Schell, M. Jimenez, L. M. Mylin, M. J. Tevethia, S. P. Schoenberger, and S. S. Tevethia. 2003. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. J. Immunol. 171: 697-707.
35. Tevethia, S. S., R. S. Greenfield, D. C. Flyer, and M. J. Tevethia. 1980. SV40 transplantation antigen: relationship to SV40-specific proteins. Cold Spring Harb. Symp. Quant. Biol. 44: 235-242.
36. Mylin, L. M., R. H. Bonneau, J. D. Lippolis, and S. S. Tevethia. 1995. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69: 6665-6677.
37. Schell, T. D., and S. S. Tevethia. 2001. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen. J. Immunol. 167: 6947-6956.
38. Schell, T. D., L. M. Mylin, I. Georgoff, A. K. Teresky, A. J. Levine, and S. S. Tevethia. 1999. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. J. Virol. 73: 5981-5993.
39. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
40. den Haan, J. M., S. M. Lehar, and M. J. Bevan. 2000. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
41. Belz, G. T., K. Shortman, M. J. Bevan, and W. R. Heath. 2005. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175: 196-200.
42. Haeryfar, S.M., H. D. Hickman, K. R. Irvine, D. C. Tscharke, J. R. Bennink, and J.W. Yewdell. 2008. Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies. J. Immunol. 181: 649-659.
43. van Heijst, J. W., C. Gerlach, E. Swart, D. Sie, C. Nunes-Alves, R. M. Kerkhoven, R. Arens, M. Correia-Neves, K. Schepers, and T. N. Schumacher. 2009. Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. Science 325: 1265-1269.
44. Zehn, D., S. Y. Lee, and M. J. Bevan. 2009. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458: 211-214.
45. Chen, W., L. C. Antón, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93.
46. Vitiello, A., L. Yuan, R. W. Chesnut, J. Sidney, S. Southwood, P. Farness, M. R. Jackson, P. A. Peterson, and A. Sette. 1996. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 157: 5555-5562.
47. Yoshimura, Y., R. Yadav, G. J. Christianson, W. U. Ajayi, D. C. Roopenian, and S. Joyce. 2004. Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. J. Immunol. 172: 6666-6674.
48. Assarsson, E., J. Sidney, C. Oseroff, V. Pasquetto, H. H. Bui, N. Frahm, C. Brander, B. Peters, H. Grey, and A. Sette. 2007. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 178: 7890-7901.
49. Pion, S., G. J. Christianson, P. Fontaine, D. C. Roopenian, and C. Perreault. 1999. Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens. Blood 93: 952-962.
50. Otahal, P., T. D. Schell, S. C. Hutchinson, B. B. Knowles, and S. S. Tevethia. 2006. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice. J. Immunol. 177: 3089-3099.
51. Wolkers, M. C., N. Brouwenstijn, A. H. Bakker, M. Toebes, and T. N. Schumacher. 2004. Antigen bias in T cell cross-priming. Science 304: 1314-1317.
52. Lev, A., K. Takeda, D. Zanker, J. C. Maynard, P. Dimberu, E. Waffarn, J. Gibbs, N. Netzer, M. F. Princiotta, L. Neckers, et al. 2008. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 28: 787-798.
53. Ma, X., A. Serna, R. H. Xu, and L. J. Sigal. 2009. The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation. J. Immunol. 182: 4601-4607.
54. van Stipdonk, M. J., G. Hardenberg, M. S. Bijker, E. E. Lemmens, N. M. Droin, D. R. Green, and S. P. Schoenberger. 2003. Dynamic programming of CD8+ T lymphocyte responses. Nat. Immunol. 4: 361-365.
55. van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2: 423-429.
56. Badovinac, V. P., B. B. Porter, and J. T. Harty. 2002. Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 3: 619-626.
57. Prlic, M., G. Hernandez-Hoyos, and M. J. Bevan. 2006. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med. 203: 2135-2143.
58. Stock, A. T., S. N. Mueller, A. L. van Lint, W. R. Heath, and F. R. Carbone. 2004. Cutting edge: prolonged antigen presentation after herpes simplex virus-1 skin infection. J. Immunol. 173: 2241-2244.
59. Brunner, M. C., C. A. Chambers, F. K. Chan, J. Hanke, A. Winoto, and J. P. Allison. 1999. CTLA-4-Mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820.